Soo-Bong Choi

  • Citations Per Year
Learn More
BACKGROUND Achieving euglycaemia by continuous subcutaneous insulin infusion (CSII) therapy alone has been shown to restore β-cell function in patients with newly diagnosed type 2 diabetes. However,(More)
  • 1